Published October 20, 2025 | Version v2
Journal article Open

Assessment of the binding patterns for endo-crine disrupting chemicals in complex with es-trogen and androgen receptors by leveraging the Asclepios Enalos KNIME nodes

Authors/Creators

Description

Abstract

Endocrine Disrupting Chemicals (EDCs) have been shown to mediate metabolic disruptions in human cells and have been associated with severe adverse health effects. By antagonizing the hormones that act on nuclear hormone receptors, like the Estrogen Receptor α (ERα) and the Androgen Receptor (AR), these chemicals disrupt the regulation of various biochemical processes thereby adversely affecting metabolic homeostasis. The expression of estrogen and androgen receptors in the liver and pancreas, which have an important role in lipid and glucose homeostasis regulation, has made them prime targets affected by EDCs. The different chemical structures of EDCs impose limitations on elucidating their binding mechanisms in nuclear receptors. In this context, in silico tools are able to highlight the potential interactions between the chemicals and the receptors. The aim of this study is to apply molecular simulation and experimental techniques to identify common patterns in the binding process of selected EDCs to ERα and AR and thus pinpoint key elements that could be characterized as molecular initiating events (MIE). MM-GBSA, and alchemical relative binding free energy (RBFE) calculations have verified the trends observed in the experimental assays regarding the binding affinity of bisphenol compounds. The findings that confirm the agreement between computational and experimental methods, offer a framework for future studies on the behaviour of ECDs with other metabolically relevant receptors.

Files

assessment-of-the-binding-patterns-for-endocrine-disrupting-chemicals-in-complex-with-estrogen-and-androgen-receptors.pdf

Files (97.1 MB)

Name Size Download all
md5:7a69dcb0b1d3d0e4aea945ce94db9faf
1.9 MB Download
md5:9a0b9fce658e1fb8789a72ccd874dca5
392.0 kB Download
md5:ae0bad8a59c564c307bbfb2b187fae4c
42.9 MB Download
md5:930aea620a8c0aee8ae7a1a54d287f57
11.3 MB Preview Download
md5:2e132087354b0a5ebbbfa96ca6f0745a
379.5 kB Download
md5:74b133e50701cc0a4a048978e6a4adfc
40.2 MB Download
md5:bd21206235f66800660d6bc30df81323
10.4 kB Download
md5:cee28919aae7ce9c228065d0f580ffad
1.2 kB Download
md5:a14efd9a175ee1a364e38dc57da9429f
1.2 kB Preview Download

Additional details

Funding

European Commission
NEMESIS - Novel Effect biomarkers for MEtabolic disruptorS: evidence on health Impacts to answer science and policy needS 101137405